Definitive Contract 75A50124C00042

Award Date 9/26/24
Potential Completion Date 1/31/29
Potential Value $41M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Sharing
Place of Performance
Austin, TX 78759, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $33,792,366.52, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Becton, Dickinson and Company (BD) for the production of multiplexed respiratory panel tests for the BD Veritor, BD MAX, and BD COR Systems. The contract, which has a completion date of June 30, 2027, is a definitive, firm-fixed-price contract and was not set aside for any specific socioeconomic category. The original solicitation was a Broad Agency...
This federal contract award, valued at $113,182,532.15, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract supports ASPR's efforts to develop medical countermeasures against chemical, biological, radiological, nuclear (CBRN) threats and pandemic influenza under the Pandemic and All Hazard Preparedness Act. The contract aims to establish a platform for the diagnosis and...
The U.S. Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), has awarded a $43,544,163 Firm Fixed Price contract to Biofire Defense LLC to advance the development of the Reveal Rapid Antibiotic Susceptibility Test (AST) System as an diagnostic countermeasure for life-threatening urgent infections. This contract, which runs through December 31, 2026, stems from a Broad Agency Announcement issued by BARDA in 2017...
The Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $618,200 firm-fixed-price contract to Bugseq Bioinformatics Inc. for the development of scalable sequencing approaches to detect novel pathogens. This contract, which has a completion date of January 31, 2024, was awarded under ASPR-22-00799, a solicitation issued under the Easy Broad Agency Announcement (EZ-BAA) from the Division of Research,...
This is a $17,325,268.78 cost-plus-fixed-fee contract awarded to Biofire Defense LLC on September 29, 2023 by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract objective is to advance the development of Biofire's Emerging Flu Panel as a nucleic acid detection assay for use on the Biofire FilmArray Torch and Spotfire platforms. This work is related to a previous Broad Agency Announcement from the Biomedical Advanced Research and Development Authority (BARDA)...
<p>This is a $41,423,587.45 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, to First Light Diagnostics, Inc. The contract is for the development of a &quot;RAPID, SENSITIVE, AND COST-EFFECTIVE ANTHRAX TEST AND CLINICAL SURGE-TESTING PLATFORM&quot; and has an ultimate completion date of November 30, 2023. The contract is a definitive contract and does not have a set-aside designation.</p>
This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...
This $5,410,602.21 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Biofire Defense LLC, a manufacturer of biological agent identification products and diagnostic solutions. The contract has an ultimate completion date of December 18, 2026 and does not utilize a set-aside designation. The contract requires Biofire Defense to provide all necessary services, personnel, material, equipment, and facilities to add the Biofire...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services, to Selux Diagnostics, Inc. as the prime contractor. The $70,578,261.84 contract is for cost plus fixed fee work and does not have a set-aside designation. The contract involves the development and delivery of products and services to support ASPR's mission. Key subcontractors include Beckman Coulter, Inc. for...
This is a $38,900,000.00 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Hologic, Inc. to ensure test availability for SARS-CoV-2 after the emergency authorization closes. The purpose is for Hologic to submit an in vitro diagnostic (IVD) assay for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) by September 30, 2027. This contract was awarded under a Broad Agency Announcement (BAA)...

This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a definitive cost-sharing contract with an ultimate completion date of January 31, 2029. This work was originally solicited through a Broad Agency Announcement from ASPR's Biomedical Advanced Research and Development Authority (BARDA) seeking advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic threats. The prime contractor was the Trustees of Boston University, who subcontracted with Pattern Bioscience to develop this rapid diagnostic platform. There was no set-aside designation for this contract award.

Generated 1/3/25, 9:13 AM